Enlivex Ltd. (ENLV)
1.11
+0.01
(+0.91%)
USD |
NASDAQ |
Sep 08, 16:00
1.13
+0.02
(+1.80%)
Pre-Market: 09:15
Enlivex EPS Diluted (Quarterly) : 386.85 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 386.85 |
| September 30, 2025 | -1.376 |
| June 30, 2025 | -1.174 |
| March 31, 2025 | -2.179 |
| December 31, 2024 | -3.283 |
| September 30, 2024 | -0.1223 |
| June 30, 2024 | -0.1584 |
| March 31, 2024 | -0.2211 |
| December 31, 2023 | -0.489 |
| September 30, 2023 | -0.3206 |
| June 30, 2023 | -0.3655 |
| March 31, 2023 | -0.3898 |
| December 31, 2022 | -0.3902 |
| September 30, 2022 | -0.3117 |
| June 30, 2022 | -0.5395 |
| March 31, 2022 | -0.4478 |
| December 31, 2021 | -0.2583 |
| September 30, 2021 | -0.187 |
| June 30, 2021 | -0.1698 |
| March 31, 2021 | -0.1942 |
| December 31, 2020 | -0.4311 |
| September 30, 2020 | -0.1578 |
| June 30, 2020 | -0.2262 |
| March 31, 2020 | -0.0697 |
| December 31, 2019 | -0.2774 |
| Date | Value |
|---|---|
| September 30, 2019 | -0.2342 |
| June 30, 2019 | -0.1445 |
| March 31, 2019 | -0.6891 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -1.36 |
| September 30, 2017 | -2.56 |
| June 30, 2017 | -4.00 |
| March 31, 2017 | -6.40 |
| December 31, 2016 | -7.60 |
| September 30, 2016 | -11.20 |
| June 30, 2016 | -8.80 |
| March 31, 2016 | -12.80 |
| December 31, 2015 | -13.60 |
| September 30, 2015 | -10.00 |
| June 30, 2015 | -10.40 |
| March 31, 2015 | -9.20 |
| December 31, 2014 | -8.80 |
| September 30, 2014 | -6.40 |
| June 30, 2014 | -4.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -3.20 |
| September 30, 2013 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Polyrizon Ltd. | -- |
| NovelStem International Corp. | -0.0017 |
| Brainstorm Cell Therapeutics, Inc. | -0.3494 |
| Summit Therapeutics, Inc. | -0.2772 |
| PeptiDream Inc. | -0.0559 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.243B |
| Total Expenses (Quarterly) | -1.243B |
| Enterprise Value | 12.34M |
| Earnings Yield | 34.43K% |
| Normalized Earnings Yield | 2388.04 |